Abivax SA (ABVX) Earnings Date & Reports

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVX is expected to report earnings to fall 15.21% to -60 cents per share on September 21

Q2'26

Est.

$-0.60

Q1'26

Missed

by $0.11

Q4'25

Missed

by $0.54

Q3'25

Missed

by $1.79

Q2'25

Missed

by $0.70

The last earnings report on May 22 showed earnings per share of -70 cents, missing the estimate of -60 cents. With 3.95M shares outstanding, the current market capitalization sits at 7.85B.

View a ticker or compare two or three

Compare

ABVX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ABVX